Journal of the American Pharmacists Association

Article	Citations
Access to community pharmacies: A nationwide geographic information systems cross-sectional analysis	96
COVID-19 and influenza vaccine hesitancy among college students	55
Prevalence and risk factors of burnout in community pharmacists	44
The impact of the COVID-19 pandemic on medical conditions and medication adherence in people with chronic diseases	44
The pharmacist’s active role in combating COVID-19 medication misinformation	35
Polypharmacy among COVID-19 patients: A systematic review	32
Essential services: Quantifying the contributions of America’s pharmacists in COVID-19 clinical interventions	31
The burden of COVID-19 on pharmacists	30
Managing medication supply chains: Lessons learned from Taiwan during the COVID-19 pandemic and preparedness planning for the future	30
Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic	28
Clinician burnout during the COVID-19 pandemic before vaccine administration	28
Systemic racism: Pharmacists’ role and responsibility	27
Expanded roles of community pharmacists in COVID-19: A scoping literature review	25
Framework to enable pharmacist access to health care data using Blockchain technology and artificial intelligence	24
Naloxone availability and dispensing in Indiana pharmacies 2 years after the implementation of a statewide standing order	24
Screening for social determinants of health in community pharmacy: Identifying best practices, barriers, and strategies for success	23
Addressing social determinants of health in community pharmacy: Innovative opportunities and practice models	22
Mental Health First Aid training and assessment among university students: A systematic review	22
Trends in gender composition on editorial boards in leading medicine, nursing, and pharmacy journals	21
The role and impact of the pharmacist in long-term care settings: A systematic review	21
Reimbursement for pharmacist-provided health care services: A multistate review	21
The impact of pharmacist involvement on immunization uptake and other outcomes: An updated systematic review and meta-analysis	20
Indiana community pharmacist preceptors’ knowledge and perceptions of medication-assisted treatment	20
The clinical impact of pharmacist services on mental health collaborative teams: A systematic review	20
Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men	20

Evaluation of naloxone access, pricing, and barriers to dispensing in Tennessee retail community pharmacies	20
The patterns and determinants of telemedicine use during the COVID-19 crisis: A nationwide study	19
Counterfeit drugs: A major issue for vulnerable citizens throughout the world and in the United States	19
Access to naloxone at community pharmacies under the Massachusetts statewide standing order	19
Association between adherence and severe asthma exacerbation: A systematic review and meta-analysis	18
Assessing pharmacy-based naloxone access using an innovative purchase trial methodology	18
Rethinking pharmacy regulation: Core elements of Idaho’s transition to a “Standard of Care” approach	17
Pharmacy technician-administered immunizations: A five-year review	17
Virtual academic detailing (e-Detailing): A vital tool during the COVID-19 pandemic	17
Revisiting pharmacy-based naloxone with pharmacists and naloxone consumers in 2 states: 2017 perspectives and evolving approaches	17
Pharmacist-provided SARS-CoV-2 testing targeting a majority-Hispanic community during the early COVID-19 pandemic: Results of a patient perception survey	16
Ability of the Well-Being Index to identify pharmacists in distress	16
The impact of medication synchronization programs on medication adherence: A meta-analysis	16
National trends in prescription proton pump inhibitor use and expenditure in the United States in 2002-2017	16
A systematic review comparing at-home diagnostic tests for SARS-CoV-2: Key points for pharmacy practice, including regulatory information	16
Pharmacist counseling when dispensing naloxone by standing order: A secret shopper study of 4 chain pharmacies	16
Adolescents’ awareness about prescription opioid misuse and preferences for educational interventions	16
Implementing outpatient antimicrobial stewardship in a primary care office through ambulatory care pharmacist-led audit and feedback	15
Access to pharmacies and pharmacy services in New York City, Los Angeles, Chicago, and Houston, 2015-2020	15
National survey identifying community pharmacist preceptors’ experience, knowledge, attitudes, and behaviors influencing intent to recommend cannabidiol products	15
North Carolina community pharmacists’ buprenorphine dispensing practices and attitudes	15
Ensuring buprenorphine access in rural community pharmacies to prevent overdoses	15
Effect of pharmacy-led interventions during care transitions on patient hospital readmission: A systematic review	15
Increasing access to care using clinical pharmacy specialist providers in outpatient mental health: Successful practice integration within the Department of Veterans Affairs	15
Antimicrobial stewardship by Australian community pharmacists: Uptake, collaboration, challenges, and needs	14
Characteristics of older adults predict concern about stopping medications	14
Community pharmacy delivered PrEP to STOP HIV transmission: An opportunity NOT to miss!	14
Characteristics of online pharmacies selling Adderall	14
Trust, influence, and community: Why pharmacists and pharmacies are central for addressing vaccine hesitancy	14
Pharmacist-led transitions-of-care services in primary care settings: Opportunities, experiences, and challenges	14
Attitudes about community pharmacy access to HIV prevention medications in California	14
Virtual pharmacist interventions on abuse of over-the-counter medications during COVID-19 versus traditional pharmacist interventions	14
Perceptions, policies, and practices related to dispensing buprenorphine for opioid use disorder: A national survey of community-based pharmacists	13
Longitudinal analysis of suicides among pharmacists during 2003-2018	13
LGBT cultural competency, patient exposure, and curricular education among student pharmacists	13
Development of a take-home naloxone program at an urban academic emergency department	13
Factors affecting the public’s knowledge about COVID-19 vaccines and the influence of knowledge on their decision to get vaccinated	12
Effects of hydrocodone rescheduling on opioid use outcomes: A systematic review	12
Comparative efficacy and safety of disease-modifying therapies in patients with relapsing multiple sclerosis: A systematic review and network meta-analysis	12
Using a pharmacist–community health worker collaboration to address medication adherence barriers	12
Diabetes outcomes before and during telehealth advancements surrounding COVID-19	12
Perceptions of working conditions and safety concerns in community pharmacy	12
Association of hospital pharmacy–related knowledge and skills with occupational stress of clinical pharmacists in tertiary hospitals of China	12
Alaska pharmacists: First responders to the pandemic in the last frontier	12
Pharmacists’ role, work practices, and safety measures against COVID-19: A comparative study	12
Hormonal contraception prescribing by pharmacists: 2019 update	12
Δ-9-tetrahydrocannabinol dose increase leads to warfarin drug interaction and elevated INR	12
The evolving role of the pharmacist for individuals with serious mental illness	12
Exploring COVID-19 vaccine hesitancy at a rural historically black college and university	12
Support and perceived barriers to implementing pre-exposure prophylaxis screening and dispensing in pharmacies: Examining concordance between pharmacy technicians and pharmacists	12

Policy solutions to address community pharmacy working conditions	12
Nationwide estimates of medication therapy management delivery under the Medicare prescription drug benefit	12
Antibiotic prescribing in the emergency department versus primary care: Implications for stewardship	11
The role of pharmacy technicians in vaccination services: a scoping review	11
An observational survey assessing the extent of PrEP and PEP furnishing in San Francisco Bay Area pharmacies	11
Pharmacy Regulatory Innovation Index: Benchmarking the regulatory environment in 10 western states	11
Efficiencies and outcomes of depression treatment by a psychiatric pharmacist in a primary care clinic compared with treatment within a behavioral health clinic	11
The pivotal role of pharmacists during the 2019 coronavirus pandemic	11
The global impact of COVID-19 on drug purchases: A cross-sectional time series analysis	11
Patient perspectives of pharmacists prescribing HIV pre-exposure prophylaxis: A survey of patients receiving antiretroviral therapy	11
Impact of a Yin Yoga and meditation intervention on pharmacy faculty and student well-being	11
Leveraging telecommuting pharmacists in the post–COVID-19 world	11
The impact of a pharmacist-led naloxone education and community distribution project on local use of naloxone	11
Pharmacy deserts: More than where pharmacies are	10
Issues of cultural competence in mental health care	10
Impact of the RESPOND Toolkit on community pharmacists’ opioid safety attitudes, self-efficacy, and knowledge	10
Exploration of pharmacist comfort with harm reduction behaviors: Cross-sectional latent class analysis	10
Pharmacist furnishing of naloxone in California: A follow-up analysis	10
Expanding access to HPV vaccination in South Carolina through community pharmacies: A geospatial analysis	10
Community pharmacist engagement in opioid use disorder prevention and treatment behaviors: A descriptive analysis	10
Evaluation of patient satisfaction and perceptions of a long-acting injectable antipsychotic medication administration service in a community-based pharmacy during the COVID-19 pandemic	10
Safety of intravenous push thiamine administration at a tertiary academic medical center	10
Virtual town halls addressing vaccine hesitancy among racial and ethnic minorities: Preliminary findings	10
Rural community pharmacists’ ability and interest in administering COVID-19 vaccines in the Southern United States	10
The clinical utility of professional continuous glucose monitoring by pharmacists for patients with type 2 diabetes	10
Pharmacists perceptions and preparedness regarding gender-affirming hormone therapy	10
Pharmacist intervention in colorectal cancer screening initiative	9
Public awareness of Mental Health First Aid and perception of community pharmacists as Mental Health First Aid providers	9
Participation in emergency preparedness and response: a national survey of pharmacists and pharmacist extenders	9
Community pharmacist workflow and medication therapy management delegation: An assessment of preferences and barriers	9
The relationship between pharmacist emotional intelligence, occupational stress, job performance, and psychological affective well-being	9
Three ways to advocate for the economic value of the pharmacist in health care	9
Naloxone accessibility without an outside prescription from U.S. community pharmacies: A systematic review	9
Patient perception of community pharmacists prescribing pre-exposure prophylaxis for HIV prevention	9
A coordinated strategy to develop and distribute infographics addressing COVID-19 vaccine hesitancy and misinformation	9
Patient experiences with pharmacist prescribed hormonal contraception in California independent and chain pharmacies	9
Pharmacist impact on pneumococcal polysaccharide vaccination rates in patients with diabetes in a national grocery chain pharmacy	9
Evaluating the impact of influenza and streptococcus point-of-care testing and collaborative practice prescribing in a community pharmacy setting	9
The U.S. medicine chest: Understanding the U.S. pharmaceutical supply chain and the role of the pharmacist	9
Pharmacist peer coaching in a traditional community chain pharmacy: Implementation and perceptions	9
Evaluating advanced pharmacy technician roles in the provision of point-of-care testing	9
Comparison of pharmacists’ mental health literacy: Developed versus developing countries	9
Facilitating pneumococcal vaccination among high-risk adults: Impact of an assertive communication training program for community pharmacists	9
Implementation of hormonal contraceptive furnishing in San Francisco community pharmacies	9
Integration of clinical pharmacists into a heart failure clinic within a safety-net hospital	9
The pharmacist’s role in SARS-CoV-2 diagnostic testing	9
Telepharmacy and medication adherence in urban areas	8
Patient perspectives of discussing social determinants of health with community pharmacists	8
Strengthening pandemic preparedness through pharmacy and public health collaborations: Findings from a facilitated discussion exercise	8
Pharmacovigilance in patients with diabetes: A data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID-19 morbidity and mortal	8
The effect of community pharmacist–led health coaching on clinical outcomes	8
Increasing adult immunization rates in a rural state through targeted pharmacist education	8
The impact of community pharmacy utilization of immunization information systems on vaccination rates: Results of a clustered randomized controlled trial	8
Implementing comprehensive pharmacogenomics in a community hospital–associated primary care setting	8
Gabapentin controlled substance status	8
Pharmacist competencies for over-the-counter hearing aids: A Delphi study	8
Factors associated with opioid-tapering success: A mixed methods study	8
Burnout and resilience among pharmacy technicians: A Singapore study	8
Impact of regulatory changes on pharmacist-delivered telehealth during the COVID-19 pandemic	8
Antimicrobial stewardship solutions with a smart innovative tool	8
Perspectives on prescribing hormonal contraception among rural New Mexican pharmacists	8
Community pharmacists’ perspectives about the sustainability of professional pharmacy services: A qualitative study	8
Impact of a clinical pharmacist on provider prescribing patterns in a primary care clinic	8
Pharmacists’ knowledge, perspectives, and experiences with mifepristone dispensing for medication abortion	8
Effects of home drug delivery on drug-related problems: preliminary evidence for improved patient outcomes during the COVID-19 pandemic in Thailand	8
Socialized and traumatized: Pharmacists, underserved patients, and the COVID-19 vaccine	8
Health information technology utilization and impact on COVID-19 vaccination	8
Community chain pharmacists’ perceptions of increased technicians’ involvement in the immunization process	8
Community pharmacist collaboration with a primary care clinic to improve diabetes care	8
Older adults’ strategies for obtaining medication refills in hypothetical scenarios in the face of COVID-19 risk	8
Impact of elective on students’ perceptions of treating patients with a substance use disorder	8
Pharmacist-led motivational interviewing for diabetes medication adherence in a worksite wellness program	8
A systematic review and meta-analysis of randomized controlled trials of cardiovascular toxicity of medical cannabinoids	8
Examining Medicare Part D Medication Therapy Management program in the context of mental health	7
Wrong drug and wrong dose dispensing errors identified in pharmacist professional liability claims	7
Evaluation of naloxone furnishing community pharmacies in San Francisco	7
Pharmacist provider status: Geoprocessing analysis of pharmacy locations, medically underserved areas, populations, and health professional shortage areas	7
Implementation and evaluation of social determinants of health practice models within community pharmacy	7
Drug and medical device product failures and the stability of the pharmaceutical supply chain	7
COVID-19 vaccine confidence project	7

Independent pharmacist prescribing of statins for patients with type 2 diabetes: An analysis of enhanced pharmacist prescriptive authority in Idaho	7
Pharmacist eConsult service for primary care medication optimization and safety	7
Psychological impact of the COVID-19 outbreak in community pharmacists: A longitudinal study	7
Community health worker perspectives of an academic community medication therapy management collaboration	7
Metabolic monitoring of second-generation antipsychotics: Evaluation of a pharmacist- and nurse-driven protocol	7
Impact of a communication technique training on rates of naloxone dispensing	7
Prescription drug disposal: Products available for home use	7
Impact of quality measures performed through pharmacist collaboration with a primary care clinic	7
Pharmacy patient perceptions of pharmacy technicians as immunizers	7
Meta-analysis comparing inappropriately low dose versus standard dose of direct oral anticoagulants in patients with atrial fibrillation	7
Association of pharmacist counseling with adherence, 30-day readmission, and mortality: A systematic review and meta-analysis of randomized trials	7
Implementation of academic detailing for pharmacists on opioid use disorder and harm reduction	7
Patient and prescriber perceptions of depression screening within a community pharmacy setting	7
Impact of pharmacist intervention on completion of recombinant zoster vaccine series in a community pharmacy	7
Access to contraception in pharmacies during the COVID-19 pandemic	7
Practice change intentions after academic detailing align with subsequent opioid prescribing	7
Pharmacy intervention to facilitate transparent opioid-risk and safety communication	7
Pharmacy deserts and patients with breast cancer receipt of influenza vaccines	7
Examining nonprescription syringe sales in Massachusetts and Rhode Island community pharmacies	7
Academic detailing with ambulatory pharmacists to support naloxone counseling	7
Investigating the impact of student loan debt on new practitioners	7
A state-level needs analysis of community pharmacy point-of-care testing	7
Revisiting the continuum of pharmacist prescriptive authority	7
Expanding pharmacists’ roles: Pharmacists’ perspectives on barriers and facilitators to collaborative practice	7
The impact of faculty and student pharmacist relationships on burnout	7
Expanding the accessibility of harm reduction services in the United States: Measuring the impact of an automated harm reduction dispensing machine	7
Assessment of literacy and numeracy skills related to medication labels in patients on chronic in-center hemodialysis	6
Developing sustainable workflows for community pharmacy–based SARS-CoV-2 testing	6
Impact of a pharmacist-run refill and prior authorization program on physician workload	6
Administration errors of compounded semaglutide reported to a poison control center—Case series	6
Pharmacists improve diabetes outcomes: a randomized controlled trial	6
Effect of drug disposal bag provision on families’ disposal of children’s unused opioids	6
Comparison of naloxone prescribing patterns due to educational outreach conducted by full-time and part-time academic detailers at the U.S. Veterans Health Administration	6
Women as first authors in key pharmacy journals: Analysis by publication type	6
Systematic review of oral pharmacotherapeutic options for the management of uterine fibroids	6
Psychometric validation of a growth Mindset and Team Communication Tool to measure self-views of growth mindset and team communication skills	6
An intersectional review of discrimination and harassment experiences in pharmacy: Findings from the 2019 National Pharmacist Workforce Survey	6
A systematic review of patient interactions with student pharmacists in educational settings	6
Evaluation of knowledge of the new Pregnancy and Lactation Labeling Rule among pharmacists and physicians	6
Community-based pharmacy use of the Pharmacist eCare Plan: A retrospective review	6
The “affected” pharmacist and the “business as usual” pharmacist: Exploring the experiences of pharmacists during COVID-19 through cluster analysis	6
Mapping the implementation of pharmacogenomic testing in community pharmacies 2003-2021 using the Theoretical Domains Framework: A scoping review	6
Reprint of: The role of the pharmacist in mental health: An investigation of the impact of pharmacist-led interventions on psychotropic medication adherence in patients with diabetes	6
The role of the pharmacist in mental health: An investigation of the impact of pharmacist-led interventions on psychotropic medication adherence in patients with diabetes	6
Identification of undocumented over-the-counter medications in an academic nephrology clinic	6
Impact of pharmacist counseling to enhance the accessibility of naloxone nasal spray to patients in a community pharmacy setting	6
Expansion of community pharmacies’ role in public vaccine delivery to children: Opportunities and need	6
Implementation of a pharmacist-delivered Medicare counseling service in a rural community health center	6
Opportunities and responsibilities for pharmacists to improve their effectiveness in addressing medication adherence through culturally sensitive collaborations with community health workers	6
Patient outcomes from implementing an enhanced services pharmacy network	6
Pharmacists’ response during a pandemic: A survey on readiness to test during COVID-19	6
A scoping review of the minority stress processes experienced by sexual and gender minority individuals in pharmacy settings: Implications for health care avoidance	6
Evaluation of an accredited training program on implementation of point-of-care testing in community pharmacies	6
Remote pharmacy service in primary care: The implementation of a cloud-based pre-prescription review system	6
Exploring the early phase of implementation of a vaccine-based clinical decision support system in the community pharmacy	6
Opportunities for pharmacist prescriptive authority of buprenorphine following passage of the Mainstreaming Addiction Treatment (MAT) Act	6
The clinical microsystems approach: Does it really work? A systematic review of organizational theories of health care practices	6
Older adults’ perceptions of deprescribing chronic benzodiazepines	6
Assistance with injectable medications: Implementation of a pharmacist-run specialty pharmacy injection clinic	6
Weight loss differences seen between glucagon-like peptide–1 receptor agonists and sodium–glucose cotransporter–2 inhibitors for treatment of type 2 diabetes	6
Perceptions of COVID-19 vaccines in a predominantly Hispanic patient population from the Texas–Mexico border	6
Pharmacists to partner with religious leaders to overcome vaccine hesitancy among Christians	6
COVID-19 era of misinformation: When your family does not trust you, will your patients?	6
Factors that influence how adults select oral over-the-counter analgesics: A systematic review	6
Implementation and assessment of a pilot, community pharmacy–based, opioid pain medication management program	6
Community pharmacists in Virginia dispensing naloxone under a standing order: A qualitative study	6
Improving access to care via psychiatric clinical pharmacist practitioner collaborative management of buprenorphine for opioid use disorder	6
Human versus machine editing of electronic prescription directions	6
Effect of pharmacists’ interventions on health outcomes of children with asthma: A systematic review	5
Patient errors in use of injectable antidiabetic medications: A need for improved clinic-based education	5
Engaging youth in the design of prescription opioid safety education for schools	5
Vitamin C and zinc lozenges for COVID-19?	5
Adult attention deficit hyperactivity disorder clinic: An interprofessional collaboration	5
Characterizing medication management and the role of pharmacists in caring for people living with cystic fibrosis: A work system approach	5
Prevalence and predictors of patients reporting adverse drug reactions to health care providers during oral targeted cancer treatment	5
Factors that influence patient acceptance of clinical pharmacy services: A nationwide survey	5
Stability and consistency of compounded oral liquid levothyroxine formulations	5
Effectiveness of an educational intervention on health risks of vaping for high school–aged adolescents	5
Managing college operations during the coronavirus outbreak	5
The decline in graduating student pharmacist positivity for the profession of pharmacy	5
Addressing buprenorphine bottlenecks in the context of MAT Act implementation: A shared responsibility	5
Pilot implementation of the PharmNet naloxone program in an independent pharmacy	5
A systematic review with meta-analysis of parental interventions for human papillomavirus vaccine uptake	5
Innovative partnership in Connecticut to expand health professional eligibility to administer COVID-19 vaccines	5
Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician	5
Knowledge about COVID-19 vaccine and vaccination in Vietnam: A population survey	5
Prescription drug monitoring programs in community pharmacy: An exploration of pharmacist time requirements and labor cost	5
Harder to get than you think: Levonorgestrel emergency contraception access in West Virginia community pharmacies	5
Increasing use of immunization information systems for routine vaccinations in independent community pharmacies: A randomized controlled trial	5
Pharmacists and Naloxone: Barriers to Dispensing and Effectiveness of an Educational Outreach Program	5
Impact of a pilot community pharmacy system redesign on reducing over-the-counter medication misuse in older adults	5
Implementation and impact assessment of integrated electronic prior authorization in an academic health system	5
COVID-19 perceptions and vaccine hesitancy: Acceptance, attitude, and barriers among Cameroonians	5
A conceptual value-based incentivization model of adult immunization for community pharmacists	5
Community pharmacists’ provision of sexual and reproductive health services: A cross-sectional study in Alberta, Canada	5